These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35311708)

  • 41. Chronic traumatic encephalopathy and aging-related tau astrogliopathy in community-dwelling older persons with and without moderate-to-severe traumatic brain injury.
    Agrawal S; Leurgans SE; Barnes LL; Dams-O'Connor K; Mez J; Bennett DA; Schneider JA
    J Neuropathol Exp Neurol; 2024 Feb; 83(3):181-193. PubMed ID: 38300796
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies.
    Colom-Cadena M; Gelpi E; Charif S; Belbin O; Blesa R; Martí MJ; Clarimón J; Lleó A
    J Neuropathol Exp Neurol; 2013 Dec; 72(12):1203-12. PubMed ID: 24226269
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterizing the emergence of amyloid and tau burden in Down syndrome.
    Zammit MD; Betthauser TJ; McVea AK; Laymon CM; Tudorascu DL; Johnson SC; Hartley SL; Converse AK; Minhas DS; Zaman SH; Ances BM; Stone CK; Mathis CA; Cohen AD; Klunk WE; Handen BL; Christian BT;
    Alzheimers Dement; 2024 Jan; 20(1):388-398. PubMed ID: 37641577
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polypathologic Associations with Gray Matter Atrophy in Neurodegenerative Disease.
    Phillips JS; Robinson JL; Cousins KAQ; Wolk DA; Lee EB; McMillan CT; Trojanowski JQ; Grossman M; Irwin DJ
    J Neurosci; 2024 Feb; 44(6):. PubMed ID: 38050082
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies.
    Bathe T; Hery GP; Villareal JAB; Phillips JL; Cohen EM; Sharma RV; Tsering W; Prokop S
    Acta Neuropathol Commun; 2024 Apr; 12(1):54. PubMed ID: 38581050
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
    Streit WJ; Braak H; Xue QS; Bechmann I
    Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brains.
    Gkanatsiou E; Sahlin C; Portelius E; Johannesson M; Söderberg L; Fälting J; Basun H; Möller C; Odergren T; Zetterberg H; Blennow K; Lannfelt L; Brinkmalm G
    Neurosci Lett; 2021 May; 754():135894. PubMed ID: 33848613
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of tau protein in neuronal damage in Alzheimer's disease and Down syndrome.
    Cárdenas AM; Ardiles AO; Barraza N; Baéz-Matus X; Caviedes P
    Arch Med Res; 2012 Nov; 43(8):645-54. PubMed ID: 23142525
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
    Attems J; Jellinger KA
    Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change and microvascular pathologies in community-dwelling older persons.
    Agrawal S; Yu L; Kapasi A; James BD; Arfanakis K; Barnes LL; Bennett DA; Nag S; Schneider JA
    Brain Pathol; 2021 May; 31(3):e12939. PubMed ID: 33624322
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.
    Vidal R; Calero M; Piccardo P; Farlow MR; Unverzagt FW; Méndez E; Jiménez-Huete A; Beavis R; Gallo G; Gomez-Tortosa E; Ghiso J; Hyman BT; Frangione B; Ghetti B
    Acta Neuropathol; 2000 Jul; 100(1):1-12. PubMed ID: 10912914
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patterns of Tau and α-Synuclein Pathology in the Visual System.
    Rahimi J; Milenkovic I; Kovacs GG
    J Parkinsons Dis; 2015; 5(2):333-40. PubMed ID: 25737267
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer's disease.
    Nicoll JAR; Buckland GR; Harrison CH; Page A; Harris S; Love S; Neal JW; Holmes C; Boche D
    Brain; 2019 Jul; 142(7):2113-2126. PubMed ID: 31157360
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mixed Brain Pathology Is the Most Common Cause of Cognitive Impairment in the Elderly.
    Alafuzoff I; Libard S
    J Alzheimers Dis; 2020; 78(1):453-465. PubMed ID: 33016922
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.
    Sierra M; Gelpi E; Martí MJ; Compta Y
    Neuropathol Appl Neurobiol; 2016 Aug; 42(5):451-62. PubMed ID: 26810462
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi.
    Smith VD; Bachstetter AD; Ighodaro E; Roberts K; Abner EL; Fardo DW; Nelson PT
    Brain Pathol; 2018 Mar; 28(2):264-273. PubMed ID: 28281308
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diffuse Lewy Body Disease and Alzheimer Disease: Neuropathologic Phenotype Associated With the PSEN1 p.A396T Mutation.
    Gondim DD; Oblak A; Murrell JR; Richardson R; Epperson F; Ross OA; Ghetti B
    J Neuropathol Exp Neurol; 2019 Jul; 78(7):585-594. PubMed ID: 31165862
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tau and TDP-43 synergy: a novel therapeutic target for sporadic late-onset Alzheimer's disease.
    Latimer CS; Liachko NF
    Geroscience; 2021 Aug; 43(4):1627-1634. PubMed ID: 34185246
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer's disease progression in Down syndrome.
    Zammit MD; Tudorascu DL; Laymon CM; Hartley SL; Zaman SH; Ances BM; Johnson SC; Stone CK; Mathis CA; Klunk WE; Cohen AD; Handen BL; Christian BT
    Neuroimage; 2021 Mar; 228():117728. PubMed ID: 33421595
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An autoradiographic evaluation of AV-1451 Tau PET in dementia.
    Lowe VJ; Curran G; Fang P; Liesinger AM; Josephs KA; Parisi JE; Kantarci K; Boeve BF; Pandey MK; Bruinsma T; Knopman DS; Jones DT; Petrucelli L; Cook CN; Graff-Radford NR; Dickson DW; Petersen RC; Jack CR; Murray ME
    Acta Neuropathol Commun; 2016 Jun; 4(1):58. PubMed ID: 27296779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.